← All news
Markets
Can Oxford Biomedica (LSE:OXB) Convert Record Client Wins Into Momentum After This Week's Interim Results?
Highlights Interim revenue rose on demand for manufacturing and development services. New client signings outpaced the total from the whole prior financial year. Management reaffirmed full-year guidance as its US site became operational. Ox…
Covered by 1 outlet
All coverage · 1 article